Table 3.
Model1 | Model2 | ||||||
Variable | OR | 95% CI | p | Variable | OR | 95% CI | p |
---|---|---|---|---|---|---|---|
osmolaritymax (<290) | 2.22 | 1.37 to 3.60 | <0.001 | osmolaritymax (<290) | 1.64 | 0.68 to 3.94 | 0.26 |
osmolaritymax (290–309) | Ref. | osmolaritymax (290–309) | Ref. | ||||
osmolaritymax (310–319) | 1.98 | 1.69 to 2.33 | <0.001 | osmolaritymax (310–319) | 1.26 | 0.89 to 1.78 | 0.18 |
osmolaritymax (320–329) | 3.20 | 2.69 to 3.82 | <0.001 | osmolaritymax (320–329) | 1.17 | 0.79 to 1.74 | 0.4 |
osmolaritymax (330–339) | 3.93 | 3.20 to 4.82 | <0.001 | osmolaritymax (330–339) | 1.51 | 0.92 to 2.46 | 0.10 |
osmolaritymax (≥340) | 4.45 | 3.58 to 5.53 | <0.001 | osmolaritymax (≥340) | 2.03 | 1.20 to 3.42 | 0.01 |
Vasopressin use | 1.89 | 1.54 to 2.31 | <0.001 | Vasopressin use | 2.05 | 1.17 to 3.57 | 0.01 |
Fluid electrolyte disorder | 1.42 | 1.25 to 1.61 | <0.001 | Congestive heart failure | 1.40 | 1.06 to 1.86 | 0.02 |
Lymphoma disease | 2.03 | 1.36 to 3.04 | 0.001 | Lymphoma disease | 3.43 | 1.57 to 7.49 | 0.01 |
Metastatic cancer | 3.16 | 2.48 to 4.01 | <0.001 | Metastatic cancer | 3.38 | 2.34 to 4.89 | <0.001 |
Maximum SOFA score | 1.23 | 1.21 to 1.25 | <0.001 | Maximum SOFA score | 1.27 | 1.22 to 1.32 | <0.001 |
Gender | 1.58 | 1.40 to 1.78 | <0.001 | ||||
Cardiac arrhythmia | 1.52 | 1.33 to 1.74 | <0.001 | ||||
Paralysis | 1.52 | 1.02 to 2.29 | 0.04 |
Notes: Model1 contains information from 14 736 patients with non–respiratory admission diagnosis and the mean VIF was 1.43. Model2 contains information from 1750 patients with respiratory admission diagnosis and the mean VIF was 1.40. osmolaritymax represents the maximum serum osmolarity during intensive care unit stay and was categorised into six levels.
SOFA, sequential organ failure assessment; VIF, variance inflation factor.